Found: 22
Select item for more details and to access through your institution.
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8876, doi. 10.3390/ijms25168876
- By:
- Publication type:
- Article
A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors.
- Published in:
- Frontiers in Neuroscience, 2017, p. 1, doi. 10.3389/fnins.2017.00521
- By:
- Publication type:
- Article
AAV-mediated chronic over-expression of SNAP-25 in adult rat dorsal hippocampus impairs memory-associated synaptic plasticity.
- Published in:
- Journal of Neurochemistry, 2010, v. 112, n. 4, p. 991, doi. 10.1111/j.1471-4159.2009.06516.x
- By:
- Publication type:
- Article
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10).
- Published in:
- Human Molecular Genetics, 2008, v. 17, n. 14, p. 2084, doi. 10.1093/hmg/ddn107
- By:
- Publication type:
- Article
Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy.
- Published in:
- European Journal of Human Genetics, 2014, v. 22, n. 11, p. 1314, doi. 10.1038/ejhg.2014.26
- By:
- Publication type:
- Article
RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD Models.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3847, doi. 10.3390/ijms24043847
- By:
- Publication type:
- Article
SARM1 Ablation Is Protective and Preserves Spatial Vision in an In Vivo Mouse Model of Retinal Ganglion Cell Degeneration.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1606, doi. 10.3390/ijms23031606
- By:
- Publication type:
- Article
Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.
- Published in:
- European Journal of Human Genetics, 2013, v. 21, n. 1, p. 62, doi. 10.1038/ejhg.2012.112
- By:
- Publication type:
- Article
Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 4, p. 642, doi. 10.1038/mt.2010.293
- By:
- Publication type:
- Article
Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 593, doi. 10.1038/mt.2008.301
- By:
- Publication type:
- Article
1020. AAV Delivery of Suppression and Replacement Constructs for Rhodopsin-Linked Autosomal Dominant Retinitis Pigmentosa<sup>*</sup>.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S392, doi. 10.1016/j.ymthe.2006.08.1115
- By:
- Publication type:
- Article
1021. Suppression and Replacement Strategies for Rhodopsin-Linked Autosomal Dominant Retinitis Pigmentosa<sup>*</sup>.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S393, doi. 10.1016/j.ymthe.2006.08.1116
- By:
- Publication type:
- Article
Gene therapies for inherited retinal disorders.
- Published in:
- Visual Neuroscience, 2014, v. 31, n. 4/5, p. 289, doi. 10.1017/S0952523814000133
- By:
- Publication type:
- Article
Direct effects of phenformin on metabolism/bioenergetics and viability of SH-SY5Y neuroblastoma cells.
- Published in:
- Oncology Letters, 2017, v. 14, n. 5, p. 6298, doi. 10.3892/ol.2017.6929
- By:
- Publication type:
- Article
AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 8, p. 1, doi. 10.1002/ctm2.952
- By:
- Publication type:
- Article
AAV-MEDIATED CHRONIC OVER-EXPRESSION OF SNAP-25 IN ADULT RAT DORSAL HIPPOCAMPUS INCREASES EXTRACELLULAR GLUTAMATE AND IMPAIRS SPATIAL LEARNING.
- Published in:
- Ulster Medical Journal, 2009, v. 78, n. 1, p. 71
- By:
- Publication type:
- Article
microRNA regulatory circuits in a mouse model of inherited retinal degeneration.
- Published in:
- Scientific Reports, 2016, p. 31431, doi. 10.1038/srep31431
- By:
- Publication type:
- Article
Optimized OPA1 Isoforms 1 and 7 Provide Therapeutic Benefit in Models of Mitochondrial Dysfunction.
- Published in:
- Frontiers in Neuroscience, 2020, v. 14, p. N.PAG, doi. 10.3389/fnins.2020.571479
- By:
- Publication type:
- Article
AAV-Delivered Tulp1 Supplementation Therapy Targeting Photoreceptors Provides Minimal Benefit in Tulp1−/− Retinas.
- Published in:
- Frontiers in Neuroscience, 2020, v. 14, p. N.PAG, doi. 10.3389/fnins.2020.00891
- By:
- Publication type:
- Article
Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-73257-z
- By:
- Publication type:
- Article
Toward an elucidation of the molecular genetics of inherited retinal degenerations.
- Published in:
- Human Molecular Genetics, 2017, v. 26, p. R2, doi. 10.1093/hmg/ddx185
- By:
- Publication type:
- Article
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 322, doi. 10.3390/pharmaceutics15020322
- By:
- Publication type:
- Article